Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 C-type lectin receptor signaling pathway 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
2 C-type lectin receptor signaling pathway 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
3 C-type lectin receptor signaling pathway 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
4 C-type lectin receptor signaling pathway 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
5 C-type lectin receptor signaling pathway 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
6 C-type lectin receptor signaling pathway 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬
7 Cytokine-cytokine receptor interaction 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
8 Cytokine-cytokine receptor interaction 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
9 Cytokine-cytokine receptor interaction 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
10 Cytokine-cytokine receptor interaction 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
11 Cytokine-cytokine receptor interaction 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
12 Cytokine-cytokine receptor interaction 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬
13 Inflammatory bowel disease 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
14 Inflammatory bowel disease 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
15 Inflammatory bowel disease 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
16 Inflammatory bowel disease 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
17 Inflammatory bowel disease 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
18 Inflammatory bowel disease 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬
19 JAK-STAT signaling pathway 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
20 JAK-STAT signaling pathway 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
21 JAK-STAT signaling pathway 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
22 JAK-STAT signaling pathway 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
23 JAK-STAT signaling pathway 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
24 JAK-STAT signaling pathway 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬
25 Pathways in cancer 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
26 Pathways in cancer 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
27 Pathways in cancer 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
28 Pathways in cancer 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
29 Pathways in cancer 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
30 Pathways in cancer 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬
31 Pertussis 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
32 Pertussis 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
33 Pertussis 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
34 Pertussis 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
35 Pertussis 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
36 Pertussis 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬
37 Rheumatoid arthritis 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
38 Rheumatoid arthritis 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
39 Rheumatoid arthritis 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
40 Rheumatoid arthritis 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
41 Rheumatoid arthritis 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬
42 Rheumatoid arthritis 💬
[1] IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
43 Th17 cell differentiation 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
44 Th17 cell differentiation 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
45 Th17 cell differentiation 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
46 Th17 cell differentiation 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
47 Th17 cell differentiation 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬
48 Th17 cell differentiation 💬
[1] IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
49 Tuberculosis 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [16] 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
50 Tuberculosis 💬
[1] IL23A 💬 Brazikumab 💬 Brazikumab [2] 96, 97 💬
51 Tuberculosis 💬
[1] IL23A 💬 Guselkumab 💬 Guselkumab [5] 37, 41, 51, 96, 97 💬
52 Tuberculosis 💬
[1] IL23A 💬 Mirikizumab 💬 Mirikizumab [3] 37, 96, 97 💬
53 Tuberculosis 💬
[1] IL23A 💬 Risankizumab 💬 Risankizumab [4] 37, 96, 97, 271 💬
54 Tuberculosis 💬
[1] IL23A 💬 Tildrakizumab 💬 Tildrakizumab [2] 162, 271 💬